UGent presented a paper on predictive factors for quality of life in patients with congestive heart failure. This paper was based on a systematic review conducted for the HeartMan project.
UGent presented a paper on predictive factors for quality of life in patients with congestive heart failure. This paper was based on a systematic review conducted for the HeartMan project.
Our partners KUL & UGent met with Belgian caregivers from the participating hospitals to discuss the personalized advice that will be given to the users and to obtain feedback on the functionalities of the HeartMan system.
A new HeartMan Project plenary meeting took place in Messina, Sicily, and it was very productive. Architecture was completed and the development is progressing quite well.
UGent & UOR met to discuss how to implement the medical guidelines and preexisting predictive models in the decision support system.
HeartMan team has been screening almost 10.000 articles for mortality, hospitalisation and quality of life. This work is being performed in the context of WP2.
HeartMan has just received approval from the ethical board to proceed with a first study into CHF patients' user needs and experiences!
The Heartman project team has celebrated its kick-off meeting
A group of prestigious scientists and health professionals from different European countries - Slovenia, Italy, Spain, Finland and Belgium - joined together to discuss some organizative details about the project.
The following organisations and institutions have joined the HeartMan consortium: Jožef Stefan Institute, Università di Roma – La Sapienza, Ghent University, CNR (Consiglio Nazionale delle Ricerche), Atos Spain, SenLab, Katholieke Universiteit Leuven, Mega Electronics Ltd & European Heart Network.
The HeartMan project started on January 2016! HeartMan is cofunded by the Horizon 2020 Framework Programme of the European Union and will design a decision support system to help the patient with Congestive Heart Failure to manage their condition.
The HeartMan consortium held its 6th Consortium Meeting in Ljubljana on 13-14 de June. The main topic was solving the remaining issues in the HeartMan system to ensure a good experience for the patients enrolled in the trial.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 689660.